These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17390428)

  • 1. Cell Signaling World: Signal Transduction Pathways as Therapeutic Targets. Proceedings of a meeting, January 25-28, 2006, Luxembourg.
    Ann N Y Acad Sci; 2006 Dec; 1091():1-570. PubMed ID: 17390428
    [No Abstract]   [Full Text] [Related]  

  • 2. Signal transduction pathways, part C. Cell signaling in health and disease. Cell signal world: signal transduction pathways as therapeutic targets. Proceedings of a meeting. January 25-28, 2006. Luxembourg.
    Ann N Y Acad Sci; 2007 Jan; 1095():1-609. PubMed ID: 17404010
    [No Abstract]   [Full Text] [Related]  

  • 3. Signal Transduction Pathways as Therapeutic Targets. 25-28 January 2004, Luxembourg.
    Keller ET
    IDrugs; 2004 Mar; 7(3):217-22. PubMed ID: 15017460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
    Sinn DI; Kim SJ; Chu K; Jung KH; Lee ST; Song EC; Kim JM; Park DK; Kun Lee S; Kim M; Roh JK
    Neurobiol Dis; 2007 May; 26(2):464-72. PubMed ID: 17398106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
    Ferrara FF; Fazi F; Bianchini A; Padula F; Gelmetti V; Minucci S; Mancini M; Pelicci PG; Lo Coco F; Nervi C
    Cancer Res; 2001 Jan; 61(1):2-7. PubMed ID: 11196162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor quisinostat activates caspase signaling and upregulates p53 acetylation to inhibit the proliferation of HepG2 cells.
    Li F; Wang T; Wang Z; Chen X; Liu R
    Mol Med Rep; 2017 Nov; 16(5):6094-6101. PubMed ID: 28849080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of Inflammation 2010-Inflammatory Cell Signaling Mechanisms as Therapeutic Targets. Luxembourg. January 27-30, 2010.
    Biochem Pharmacol; 2010 Dec; 80(12):1769-2100. PubMed ID: 21157995
    [No Abstract]   [Full Text] [Related]  

  • 8. Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites.
    Kim S; Kang JK; Kim YK; Seo DW; Ahn SH; Lee JC; Lee CH; You JS; Cho EJ; Lee HW; Han JW
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1168-73. PubMed ID: 16516150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite effects of histone deacetylase inhibitors on glucocorticoid and estrogen signaling in human endometrial Ishikawa cells.
    Rocha W; Sanchez R; Deschênes J; Auger A; Hébert E; White JH; Mader S
    Mol Pharmacol; 2005 Dec; 68(6):1852-62. PubMed ID: 16186250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
    Jagannathan J; Prevedello DM; Dumont AS; Laws ER
    Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC.
    Dong W; Jia Y; Liu X; Zhang H; Li T; Huang W; Chen X; Wang F; Sun W; Wu H
    J Endocrinol; 2017 Jan; 232(1):71-83. PubMed ID: 27799462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
    Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
    Zhang HS; Chen XY; Wu TC; Zhang FJ
    J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells.
    Portanova P; Russo T; Pellerito O; Calvaruso G; Giuliano M; Vento R; Tesoriere G
    Int J Oncol; 2008 Aug; 33(2):325-31. PubMed ID: 18636153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the 9th International Meeting of Signal Transduction and gene expression, Cell Signalomics 2011 – Integrated cellular pathology – Systems biology of human disease, January 26-29, 2011, Luxembourg.
    Biochem Pharmacol; 2011 Nov; 82(10):1253-1520. PubMed ID: 22175071
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of oxidative stress in the increased activation of signal transducers and activators of transcription-3 in the fatty livers of obese Zucker rats.
    Dikdan GS; Saba SC; Dela Torre AN; Roth J; Wang S; Koneru B
    Surgery; 2004 Sep; 136(3):677-85. PubMed ID: 15349118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy.
    Pennington JD; Wang TJ; Nguyen P; Sun L; Bisht K; Smart D; Gius D
    Drug Resist Updat; 2005 Oct; 8(5):322-30. PubMed ID: 16230045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Nrf2 pathway as a potential therapeutic target for Huntington disease A commentary on "Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington disease".
    Escartin C; Brouillet E
    Free Radic Biol Med; 2010 Jul; 49(2):144-6. PubMed ID: 20399852
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of resistance to histone deacetylase inhibitors.
    Lee JH; Choy ML; Marks PA
    Adv Cancer Res; 2012; 116():39-86. PubMed ID: 23088868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells.
    Bartoli A; Fettucciari K; Fetriconi I; Rosati E; Di Ianni M; Tabilio A; Delfino DV; Rossi R; Marconi P
    Pharmacol Res; 2003 Jul; 48(1):111-8. PubMed ID: 12770523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.